Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.45M
5 trades · 3 insiders
Net · 90d
$-1.45M
Insiders on file
21
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| McFarlane Neil F. | President and CEO, Director | 23 | $0 | $2.14M | 2026-10-12 |
| Thompson Rahsaan | Chief Legal & Compliance | 17 | $0 | $1.67M | 2026-08-14 |
| Watton Corey Michael | Director | 15 | $11.8K | $276.8K | 2026-08-10 |
| Anderson Thomas | Director | 6 | $116.9K | $0 | 2026-06-04 |
| Shih Alvin | Director | 5 | $157.8K | $0 | 2026-06-04 |
| Secor Alicia | Director | 2 | $0 | $0 | 2026-06-04 |
| Calder Douglas W | Director | 4 | $0 | $0 | 2026-06-04 |
| SEYMOUR TAMARA A | Director | 7 | $27.2K | $0 | 2026-06-04 |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controller | 16 | $5.0K | $66.6K | 2026-05-28 |
| Bode John B | Director | 17 | $285.9K | $0 | 2026-03-24 |
| Renz Justin A | CFO | 1 | $0 | $0 | 2026-03-18 |
| Schafer Joshua | CCO & EVP, Bus. Development | 17 | $17.2K | $208.8K | 2026-02-03 |
| Quartel Adrian W | Chief Medical Officer | 7 | $0 | $40.0K | 2026-01-30 |
| Clifton R. LaDuane | Other | 17 | $39.2K | $86.5K | 2025-12-31 |
| DIXON WENDY L | Director | 4 | $0 | $0 | 2025-05-29 |
| Guenther Sven | Chief Scientific Officer | 1 | $0 | $0 | 2024-01-31 |
| Mickle Christal M M | Chief Development Officer | 1 | $0 | $0 | 2024-01-31 |
| Plooster Matthew R | Director | 2 | $46.2K | $0 | 2023-04-25 |
| Saluri Joseph | Director | 1 | $0 | $0 | 2023-04-25 |
| Pascoe Richard W | Chief Executive Officer | 1 | $42.0K | $0 | 2023-03-09 |
| Tierney David S | Director | 1 | $20.8K | $0 | 2023-03-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| McFarlane Neil F. | President and CEO, Director | S Sale | 2026-10-12 | 2026-10-13 | 20,000 | $11.25 | $224.9K | 417,225 | SEC↗ |
| McFarlane Neil F. | President and CEO, Director | M Exercise deriv | 2026-10-10 | 2026-10-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| McFarlane Neil F. | President and CEO, Director | M Exercise | 2026-10-10 | 2026-10-13 | 50,000 | — | — | 437,225 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | S Sale | 2026-08-14 | 2026-08-17 | 42,666 | $11.13 | $474.9K | 37,569 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | S Sale | 2026-08-14 | 2026-08-17 | 42,666 | $11.13 | $474.8K | 37,569 | SEC↗ |
| Watton Corey Michael | Director | M Exercise deriv | 2026-08-10 | 2026-08-12 | 12,300 | — | $0 | 46,500 | SEC↗ |
| Watton Corey Michael | Director | S Sale | 2026-08-10 | 2026-08-12 | 12,300 | $11.25 | $138.4K | 1,800 | SEC↗ |
| Watton Corey Michael | Director | M Exercise | 2026-08-10 | 2026-08-12 | 12,300 | $4.97 | $61.1K | 14,100 | SEC↗ |
| Watton Corey Michael | Director | M Exercise deriv | 2026-08-10 | 2026-08-12 | 12,300 | — | $0 | 46,500 | SEC↗ |
| Watton Corey Michael | Director | S Sale | 2026-08-10 | 2026-08-12 | 12,300 | $11.25 | $138.4K | 1,800 | SEC↗ |
| Watton Corey Michael | Director | M Exercise | 2026-08-10 | 2026-08-12 | 12,300 | $4.97 | $61.1K | 14,100 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | S Sale | 2026-06-22 | 2026-06-23 | 34,557 | $12.68 | $438.2K | 80,235 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | M Exercise deriv | 2026-06-21 | 2026-06-23 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | M Exercise | 2026-06-21 | 2026-06-23 | 66,667 | — | $0 | 114,792 | SEC↗ |
| Shih Alvin | Director | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Anderson Thomas | Director | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Calder Douglas W | Director | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Watton Corey Michael | Director | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Secor Alicia | Director | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FAVORITO TAMARA A | Director | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | A Award deriv | 2026-05-28 | 2026-05-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | A Award deriv | 2026-05-28 | 2026-05-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | S Sale | 2026-05-11 | 2026-05-13 | 1,794 | $11.30 | $20.3K | 48,125 | SEC↗ |
| Bode John B | Director | M Exercise deriv | 2026-03-24 | 2026-03-26 | 39,200 | — | $0 | 19,600 | SEC↗ |
| Bode John B | Director | M Exercise deriv | 2026-03-24 | 2026-03-26 | 39,200 | — | $0 | 0 | SEC↗ |
| Bode John B | Director | M Exercise | 2026-03-24 | 2026-03-26 | 39,200 | $4.89 | $191.7K | 123,400 | SEC↗ |
| Bode John B | Director | M Exercise | 2026-03-24 | 2026-03-26 | 39,200 | $4.97 | $194.8K | 84,200 | SEC↗ |
| Renz Justin A | CFO | A Award deriv | 2026-03-18 | 2026-03-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | S Sale | 2026-02-09 | 2026-02-10 | 14,625 | $8.56 | $125.2K | 387,225 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise deriv | 2026-02-07 | 2026-02-10 | 37,500 | — | $0 | 75,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise | 2026-02-07 | 2026-02-10 | 37,500 | — | $0 | 401,850 | SEC↗ |
| Schafer Joshua | CCO | S Sale | 2026-02-03 | 2026-02-04 | 10,500 | $9.19 | $96.5K | 62,278 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | S Sale | 2026-02-03 | 2026-02-04 | 3,000 | $9.18 | $27.5K | 29,590 | SEC↗ |
| McFarlane Neil F. | President and CEO | S Sale | 2026-02-02 | 2026-02-02 | 91,000 | $9.38 | $853.6K | 364,350 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise deriv | 2026-01-31 | 2026-02-02 | 233,334 | — | $0 | 233,333 | SEC↗ |
| Schafer Joshua | CCO | M Exercise deriv | 2026-01-31 | 2026-02-02 | 35,334 | — | $0 | 35,333 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | M Exercise deriv | 2026-01-31 | 2026-02-02 | 11,666 | — | $0 | 11,668 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise | 2026-01-31 | 2026-02-02 | 233,334 | — | $0 | 455,350 | SEC↗ |
| Schafer Joshua | CCO | M Exercise | 2026-01-31 | 2026-02-02 | 35,334 | — | $0 | 72,778 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | M Exercise | 2026-01-31 | 2026-02-02 | 11,666 | — | $0 | 32,590 | SEC↗ |
| Schafer Joshua | CCO | M Exercise deriv | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 22,667 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | M Exercise deriv | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 22,667 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | M Exercise deriv | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 22,667 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | M Exercise deriv | 2026-01-30 | 2026-02-02 | 6,333 | — | $0 | 12,667 | SEC↗ |
| Schafer Joshua | CCO | S Sale | 2026-01-30 | 2026-02-02 | 3,375 | $8.83 | $29.8K | 37,444 | SEC↗ |
| Schafer Joshua | CCO | M Exercise | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 40,819 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | M Exercise | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 14,256 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | S Sale | 2026-01-30 | 2026-02-02 | 4,533 | $8.83 | $40.0K | 9,723 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | M Exercise | 2026-01-30 | 2026-02-02 | 11,333 | — | $0 | 53,999 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | S Sale | 2026-01-30 | 2026-02-02 | 4,080 | $8.83 | $36.0K | 49,919 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | M Exercise | 2026-01-30 | 2026-02-02 | 6,333 | — | $0 | 22,674 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | S Sale | 2026-01-30 | 2026-02-02 | 1,750 | $8.82 | $15.4K | 20,924 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2026-01-29 | 2026-02-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2026-01-29 | 2026-02-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Schafer Joshua | CCO | A Award deriv | 2026-01-29 | 2026-02-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Schafer Joshua | CCO | A Award deriv | 2026-01-29 | 2026-02-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2026-01-29 | 2026-02-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2026-01-29 | 2026-02-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | A Award deriv | 2026-01-29 | 2026-02-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | A Award deriv | 2026-01-29 | 2026-02-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Clifton R. LaDuane | Other | M Exercise deriv | 2025-12-31 | 2026-01-07 | 20,000 | — | $0 | 0 | SEC↗ |
| Clifton R. LaDuane | Other | M Exercise deriv | 2025-12-31 | 2026-01-07 | 34,000 | — | $0 | 0 | SEC↗ |
| Clifton R. LaDuane | Other | M Exercise deriv | 2025-12-31 | 2026-01-07 | 86,667 | — | $0 | 0 | SEC↗ |
| Clifton R. LaDuane | Other | M Exercise | 2025-12-31 | 2026-01-07 | 140,667 | — | $0 | 192,028 | SEC↗ |
| Clifton R. LaDuane | Other | F Tax w/h | 2025-12-31 | 2026-01-07 | 48,513 | $8.96 | $434.7K | 143,515 | SEC↗ |
| Secor Alicia | Director | A Award deriv | 2025-12-02 | 2025-12-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise deriv | 2025-10-10 | 2025-10-10 | 50,000 | — | $0 | 100,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | S Sale | 2025-10-10 | 2025-10-10 | 19,500 | $10.82 | $211.0K | 222,016 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise | 2025-10-10 | 2025-10-10 | 50,000 | — | $0 | 241,516 | SEC↗ |
| Shih Alvin | Director | P Buy | 2025-09-12 | 2025-09-15 | 20,000 | $7.89 | $157.8K | 20,000 | SEC↗ |
| FAVORITO TAMARA A | Director | P Buy | 2025-09-12 | 2025-09-16 | 3,175 | $7.79 | $24.7K | 3,894 | SEC↗ |
| Bode John B | Director | P Buy | 2025-08-19 | 2025-08-20 | 5,000 | $9.17 | $45.9K | 45,000 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | S Sale | 2025-06-26 | 2025-06-30 | 24,000 | $9.21 | $221.0K | 42,666 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | M Exercise deriv | 2025-06-21 | 2025-06-24 | 66,666 | — | $0 | 133,334 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | M Exercise | 2025-06-21 | 2025-06-24 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Anderson Thomas | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Bode John B | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Watton Corey Michael | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FAVORITO TAMARA A | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Calder Douglas W | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DIXON WENDY L | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Shih Alvin | Director | A Award deriv | 2025-05-29 | 2025-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Watton Corey Michael | Director | P Buy | 2025-03-28 | 2025-03-31 | 300 | $7.84 | $2.4K | 1,800 | SEC↗ |
| Bode John B | Director | P Buy | 2025-03-19 | 2025-03-21 | 10,000 | $7.96 | $79.6K | 40,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | S Sale | 2025-02-14 | 2025-02-14 | 30,544 | $8.05 | $245.9K | 191,516 | SEC↗ |
| McFarlane Neil F. | President and CEO | S Sale | 2025-02-13 | 2025-02-14 | 61,273 | $7.86 | $481.6K | 222,060 | SEC↗ |
| Clifton R. LaDuane | CFO & Treasurer | S Sale | 2025-02-13 | 2025-02-14 | 11,000 | $7.86 | $86.5K | 51,361 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | S Sale | 2025-02-13 | 2025-02-14 | 10,500 | $7.86 | $82.5K | 29,486 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | S Sale | 2025-02-13 | 2025-02-14 | 3,000 | $7.86 | $23.6K | 16,341 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2025-02-07 | 2025-02-10 | 225,000 | — | $0 | 225,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2025-02-07 | 2025-02-10 | 112,500 | — | $0 | 112,500 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise deriv | 2025-01-31 | 2025-02-03 | 233,333 | — | $0 | 466,667 | SEC↗ |
| Clifton R. LaDuane | CFO & Treasurer | M Exercise deriv | 2025-01-31 | 2025-02-03 | 43,333 | — | $0 | 86,667 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | M Exercise deriv | 2025-01-31 | 2025-02-03 | 35,333 | — | $0 | 70,667 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | M Exercise deriv | 2025-01-31 | 2025-02-03 | 11,666 | — | $0 | 23,334 | SEC↗ |
| McFarlane Neil F. | President and CEO | M Exercise | 2025-01-31 | 2025-02-03 | 233,333 | — | $0 | 283,333 | SEC↗ |
| Clifton R. LaDuane | CFO & Treasurer | M Exercise | 2025-01-31 | 2025-02-03 | 43,333 | — | $0 | 62,361 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | M Exercise | 2025-01-31 | 2025-02-03 | 35,333 | — | $0 | 39,986 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | M Exercise | 2025-01-31 | 2025-02-03 | 11,666 | — | $0 | 19,341 | SEC↗ |
| Clifton R. LaDuane | CFO & Treasurer | A Award deriv | 2025-01-30 | 2025-02-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Clifton R. LaDuane | CFO & Treasurer | A Award deriv | 2025-01-30 | 2025-02-03 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | A Award deriv | 2025-01-30 | 2025-02-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | A Award deriv | 2025-01-30 | 2025-02-03 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | A Award deriv | 2025-01-30 | 2025-02-03 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | A Award deriv | 2025-01-30 | 2025-02-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | A Award deriv | 2025-01-30 | 2025-02-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controll | A Award deriv | 2025-01-30 | 2025-02-03 | 38,000 | — | $0 | 38,000 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2025-01-30 | 2025-03-27 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Quartel Adrian W | Chief Medical Officer | A Award deriv | 2025-01-30 | 2025-03-27 | 68,000 | — | $0 | 68,000 | SEC↗ |
| Watton Corey Michael | Director | P Buy | 2024-10-11 | 2024-10-16 | 500 | $7.92 | $4.0K | 1,500 | SEC↗ |
| Clifton R. LaDuane | CFO & Treasurer | P Buy | 2024-07-17 | 2024-07-17 | 2,000 | $6.77 | $13.5K | 18,469 | SEC↗ |
| Anderson Thomas | Director | P Buy | 2024-07-16 | 2024-07-16 | 10,000 | $6.81 | $68.1K | 20,000 | SEC↗ |
| Bode John B | Director | P Buy | 2024-07-12 | 2024-07-15 | 10,000 | $5.87 | $58.7K | 30,000 | SEC↗ |
| Thompson Rahsaan | Chief Legal & Compliance | A Award deriv | 2024-06-21 | 2024-06-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Anderson Thomas | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 39,200 | — | $0 | 39,200 | SEC↗ |
| Shih Alvin | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 39,200 | — | $0 | 39,200 | SEC↗ |
| Watton Corey Michael | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 39,200 | — | $0 | 39,200 | SEC↗ |
| Calder Douglas W | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 39,200 | — | $0 | 39,200 | SEC↗ |
| FAVORITO TAMARA A | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 49,200 | — | $0 | 49,200 | SEC↗ |
| DIXON WENDY L | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 39,200 | — | $0 | 39,200 | SEC↗ |
| Bode John B | Director | A Award deriv | 2024-05-13 | 2024-05-15 | 39,200 | — | $0 | 39,200 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2024-01-31 | 2024-02-02 | 700,000 | — | $0 | 700,000 | SEC↗ |
| Clifton R. LaDuane | CFO, Secretary & Treasurer | A Award deriv | 2024-01-31 | 2024-02-02 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Guenther Sven | Chief Scientific Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 79,000 | — | $0 | 79,000 | SEC↗ |
| Mickle Christal M M | Chief Development Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Corporate Controller | A Award deriv | 2024-01-31 | 2024-02-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | A Award deriv | 2024-01-31 | 2024-02-02 | 106,000 | — | $0 | 106,000 | SEC↗ |
| Shih Alvin | Director | A Award deriv | 2024-01-20 | 2024-02-02 | 58,800 | — | $0 | 58,800 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2023-10-10 | 2023-10-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| McFarlane Neil F. | President and CEO | A Award deriv | 2023-10-10 | 2023-10-11 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Anderson Thomas | Director | P Buy | 2023-09-06 | 2023-09-06 | 10,000 | $4.88 | $48.8K | 10,000 | SEC↗ |
| Clifton R. LaDuane | CFO, Secretary & Treasurer | P Buy | 2023-09-06 | 2023-09-06 | 1,000 | $4.96 | $5.0K | 15,309 | SEC↗ |
| Bode John B | Director | P Buy | 2023-09-05 | 2023-09-06 | 10,000 | $5.13 | $51.3K | 20,000 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | P Buy | 2023-09-05 | 2023-09-06 | 500 | $5.13 | $2.6K | 3,500 | SEC↗ |
| Anderson Thomas | Director | A Award deriv | 2023-08-07 | 2023-08-25 | 58,800 | — | $0 | 58,800 | SEC↗ |
| Watton Corey Michael | Director | P Buy | 2023-06-23 | 2023-06-26 | 275 | $5.95 | $1.6K | 1,000 | SEC↗ |
| Watton Corey Michael | Director | P Buy | 2023-06-09 | 2023-06-13 | 325 | $5.52 | $1.8K | 725 | SEC↗ |
| FAVORITO TAMARA A | Director | A Award deriv | 2023-05-31 | 2023-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Watton Corey Michael | Director | P Buy | 2023-05-30 | 2023-05-31 | 400 | $5.11 | $2.0K | 400 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | P Buy | 2023-05-19 | 2023-06-30 | 1,000 | $5.42 | $5.4K | 3,000 | SEC↗ |
| Clifton R. LaDuane | CFO, Secretary & Treasurer | P Buy | 2023-05-18 | 2023-05-18 | 689 | $4.95 | $3.4K | 13,742 | SEC↗ |
| Clifton R. LaDuane | CFO, Secretary & Treasurer | P Buy | 2023-05-18 | 2023-05-18 | 51 | $4.94 | $252 | 11,053 | SEC↗ |
| Clifton R. LaDuane | CFO, Secretary & Treasurer | P Buy | 2023-05-18 | 2023-05-18 | 2,000 | $4.95 | $9.9K | 13,053 | SEC↗ |
| Bode John B | Director | P Buy | 2023-05-18 | 2023-05-19 | 2,451 | $5.05 | $12.4K | 10,000 | SEC↗ |
| Bode John B | Director | P Buy | 2023-05-18 | 2023-05-19 | 100 | $5.05 | $505 | 7,549 | SEC↗ |
| Bode John B | Director | P Buy | 2023-05-18 | 2023-05-19 | 4,759 | $5.04 | $24.0K | 7,449 | SEC↗ |
| Bode John B | Director | P Buy | 2023-05-18 | 2023-05-19 | 1,000 | $5.04 | $5.0K | 2,690 | SEC↗ |
| Bode John B | Director | P Buy | 2023-05-18 | 2023-05-19 | 300 | $5.04 | $1.5K | 1,690 | SEC↗ |
| Bode John B | Director | P Buy | 2023-05-18 | 2023-05-19 | 1,390 | $5.04 | $7.0K | 1,390 | SEC↗ |
| Bode John B | Director | A Award deriv | 2023-05-03 | 2023-05-08 | 58,800 | — | $0 | 58,800 | SEC↗ |
| DIXON WENDY L | Director | A Award deriv | 2023-05-03 | 2023-05-08 | 36,300 | — | $0 | 36,300 | SEC↗ |
| Watton Corey Michael | Director | A Award deriv | 2023-05-03 | 2023-05-08 | 58,800 | — | $0 | 58,800 | SEC↗ |
| Calder Douglas W | Director | A Award deriv | 2023-05-03 | 2023-05-11 | 58,800 | — | $0 | 58,800 | SEC↗ |
| DIXON WENDY L | Director | A Award deriv | 2023-04-25 | 2023-05-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| FAVORITO TAMARA A | Director | A Award deriv | 2023-04-25 | 2023-05-08 | 39,200 | — | $0 | 39,200 | SEC↗ |
| Plooster Matthew R | Director | A Award deriv | 2023-04-25 | 2023-05-08 | 49,200 | — | $0 | 49,200 | SEC↗ |
| Saluri Joseph | Director | A Award deriv | 2023-04-25 | 2023-05-08 | 39,200 | — | $0 | 39,200 | SEC↗ |
| SEYMOUR TAMARA A | Director | P Buy | 2023-03-17 | 2023-03-21 | 519 | $4.82 | $2.5K | 719 | SEC↗ |
| Schafer Joshua | CCO & EVP, Bus. Development | P Buy | 2023-03-14 | 2023-03-15 | 2,000 | $4.61 | $9.2K | 2,000 | SEC↗ |
| Clifton R. LaDuane | CFO, Secretary & Treasurer | P Buy | 2023-03-10 | 2023-03-13 | 1,725 | $4.15 | $7.2K | 11,002 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Corporate Controller | P Buy | 2023-03-10 | 2023-03-13 | 100 | $4.14 | $414 | 4,449 | SEC↗ |
| Sangiovanni Timothy J. | SVP, Corporate Controller | P Buy | 2023-03-10 | 2023-03-13 | 1,100 | $4.14 | $4.6K | 4,349 | SEC↗ |
| Pascoe Richard W | Chief Executive Officer | P Buy | 2023-03-09 | 2023-03-13 | 10,000 | $4.20 | $42.0K | 29,973 | SEC↗ |
| Tierney David S | Director | P Buy | 2023-03-09 | 2023-03-13 | 5,000 | $4.15 | $20.8K | 10,835 | SEC↗ |
| Plooster Matthew R | Director | P Buy | 2023-03-09 | 2023-03-13 | 11,000 | $4.20 | $46.2K | 18,500 | SEC↗ |